The final analysis of the succesful EXALT-1 interventional trial will be presented at the 62nd annual meeting of the American Society for Hematology by Prof. Dr. Philipp Staber from the Medical University of Vienna!
In the EXALT-1 trial, Pharmacoscopy has been used to guide the treatment of patients with advanced aggressive hematological cancers. A preview of the final analysis is available online here: Treatments guided by Pharmacoscopy led to improved progression free survival for 30 out of 56 patients!